Grace Therapeutics, Inc. (GRCE)
Operating Income
-$15.79M
Quarterly · Period ending: · USD
GRCE Operating Income
Latest reported-$15.79Mperiod ending
Latest reported-$15.79Mperiod ending
GRCE Quarterly Operating Income (-$188.82K → -$15.79M)
Quarterly operating income
High-resolution chart · PNG
GRCE operating income history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income (USD) |
|---|---|
| -15,790,000 | |
| -3,010,000 | |
| -3,360,346 | |
| -3,527,272 | |
| -3,090,000 | |
| -4,532,942 | |
| -5,326,685 | |
| -4,831,000 | |
| -6,787,547 | |
| -4,427,923 | |
| -4,033,474 | |
| -2,833,049 | |
| -5,900,495 | |
| -51,494,938 | |
| -5,703,763 | |
| -5,108,000 | |
| -6,090,213 | |
| -5,501,431 | |
| -5,702,041 | |
| -4,519,686 | |
| -4,810,371 | |
| -3,629,757 | |
| -3,202,149 | |
| -14,224,258 | |
| -7,580,280 | |
| -5,175,500 | |
| -6,146,000 | |
| -6,255,000 | |
| -8,006,000 | |
| -10,901,777 | |
| -7,863,262 | |
| -8,078,884 | |
| -7,544,860 | |
| -5,443,196 | |
| -4,095,427 | |
| -3,534,779 | |
| -2,712,983 | |
| -1,869,687 | |
| -1,871,557 | |
| -2,268,719 | |
| -1,556,520 | |
| -1,969,455 | |
| -1,631,223 | |
| -2,099,373 | |
| -1,708,105 | |
| -2,588,114 | |
| -3,177,686 | |
| -2,737,844 | |
| -1,652,852 | |
| -3,121,381 | |
| -3,091,059 | |
| -1,918,713 | |
| -1,797,293 | |
| -1,637,023 | |
| -1,753,928 | |
| -1,571,358 | |
| -1,749,291 | |
| -2,143,023 | |
| -1,763,240 | |
| -1,043,007 | |
| -1,015,873 | |
| -772,248 | |
| -641,704 | |
| -512,599 | |
| -419,928 | |
| -378,710 | |
| -451,351 | |
| -264,636 | |
| -188,817 |